Literature DB >> 2051733

Heterogeneity of immune complex-derived anti-DNA antibodies associated with lupus nephritis.

T Sasaki1, A Hatakeyama, S Shibata, H Osaki, M Suzuki, K Horie, Y Kitagawa, K Yoshinaga.   

Abstract

The mechanisms responsible for the tissue injuries associated with lupus nephritis have not yet been well explained. We have investigated the characteristics of anti-DNA antibodies in circulating immune complexes (CIC) and in the deposits of renal glomeruli in patients with active lupus nephritis. The CIC-derived antibodies expressed anti-DNA idiotypes (Id) designated as 0-81 Id and NE-1 Id, and bound mainly to single-stranded DNA but never to glomerular basement membrane (GBM) antigens. On the other hand, the immunoglobulins (Ig) eluted from renal glomeruli of lupus patients reacted not only with DNA but also with GBM, proteoglycan, and heparan sulfate. The binding of glomeruli-deposited Ig was markedly low when GBM antigens were used after treatment with heparitinase, suggesting that some anti-DNA antibodies may bind directly to GBM antigens associated with heparan sulfate, and form in situ IC in renal glomeruli. It was also revealed that the renal eluates obtained after passing through GBM antigen-coupled Sepharose lost the binding ability with GBM but still retained DNA-binding and 0-81 Id activity, showing the participation of circulating IC-derived anti-DNA antibodies in the glomerular deposits. Theoretically there may be two mechanisms in the pathogenesis of lupus nephritis through the deposition of circulating IC and through in situ formation of anti-DNA IC in renal glomeruli. The diversity of histological features in lupus kidneys may be attributed to the heterogeneity of the mechanisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051733     DOI: 10.1038/ki.1991.91

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Specific increases in urinary excretion of anti-DNA antibodies in lupus mice induced by lysozyme administration: further evidence for DNA-anti-DNA immune complexes in the pathogenesis of nephritis.

Authors:  T Yamamoto; M Nagase; A Hishida; N Honda
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

2.  Anti-DNA antibodies cross-react with C1q.

Authors:  Giovanni Franchin; Myoungsun Son; Sun Jung Kim; Ilan Ben-Zvi; Jie Zhang; Betty Diamond
Journal:  J Autoimmun       Date:  2013-07-05       Impact factor: 7.094

3.  Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; a long term prospective analysis.

Authors:  C Kramers; R M Termaat; E J ter Borg; M C van Bruggen; C G Kallenberg; J H Berden
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

4.  Detection of glomerular-binding immune elements in murine lupus using a tissue-based ELISA.

Authors:  K Bernstein; D Bolshoun; G Gilkeson; T Munns; J B Lefkowith
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

5.  An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus.

Authors:  L Budhai; K Oh; A Davidson
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

6.  Independently derived murine glomerular immune deposit-forming anti-DNA antibodies are encoded by near-identical VH gene sequences.

Authors:  M S Katz; M H Foster; M P Madaio
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

Review 7.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

8.  No evidence for an independent role of anti-heparan sulphate reactivity apart from anti-DNA in lupus nephritis.

Authors:  M N Hylkema; I V Zwet; C Kramers; M C Van Bruggen; A J Swaak; J H Berden; R J Smeenk
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

9.  The Pathogenesis of Lupus Nephritis.

Authors:  Rosalie M Sterner; Stella P Hartono; Joseph P Grande
Journal:  J Clin Cell Immunol       Date:  2014-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.